Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02088060
Recruitment Status : Active, not recruiting
First Posted : March 14, 2014
Last Update Posted : August 14, 2019
Sponsor:
Collaborators:
Martin-Luther-Universität Halle-Wittenberg
Heidelberg University
Technische Universität München
Ludwig-Maximilians - University of Munich
Glostrup University Hospital, Copenhagen
Information provided by (Responsible Party):
Central Institute of Mental Health, Mannheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : December 2021